hotspot -WSS

hotspot

author：comprehensive 2025-10-01 15:29:56 - browse：519

Balance innovation — A federal judge made a key ruling in a lawsuit challenging a new drug pricing program Adobe

WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional.

The case centers on Democrats’ new law, which empowered the Medicare program to start negotiating lower prices for certain medicines that are especially expensive for the government. Judge Michael Newman, a Trump appointee to the U.S. District Court for the Southern District of Ohio, ruled against the U.S. Chamber of Commerce, which had sued the federal government and asked for the program to be stopped while litigation continues.

Medicare officials announced the first 10 drugs they would negotiate over last month, and the deadline for the pharmaceutical companies to sign agreements to start bargaining is Oct. 1. The Chamber of Commerce had requested a decision on the preliminary injunction by that date.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： UnitedHealth CEO's Medicaid comments send insurer stocks diving

focus

entertainment

focus

WSS

He's 19 months old and has one of the world’s rarest diseases

Sutter Health’s antitrust win overturned by appeals court

An outdated Medicare rule harms dementia patients with anxiety

CMS got Medicare Advantage quality rating wrong, judge rules

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

He's 19 months old and has one of the world’s rarest diseases

hotspot

hotspot

explore

Affirmative action in medical school literally saved lives

For AI in health care standards, federal regulators join with industry group

How one medical school became remarkably diverse

Streamlined flu vaccines recommended by FDA advisory panel

At least 13 dead in Texas as scorching temps continue

FTC loses bid to block Novant's North Carolina hospital merger

The high cost of giving birth even with insurance

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Affirmative action in medical school literally saved lives

The most pressing bird flu mysteries scientists want answered

explore

Harvard's David Sinclair gets blowback over aging

Sutter Health’s antitrust win overturned by appeals court

BD to buy Edwards patient monitoring unit for $4.2 billion

IVF doctors demand details after CooperSurgical lawsuit

FDA approves Moderna’s RSV vaccine, its second licensed product

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

focus

entertainment

focus

hotspot